Richard Pzena Charles River Laboratories International, Inc. Transaction History

Pzena Investment Management LLC

  • $30.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 08, 2019
SELL
$105.09 - $137.23 $590,080 - $770,546
-5,615 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
$112.11 - $134.54 $380,052 - $456,090
3,390 Added 152.36%
5,615 $755,000
Q2 2018

Aug 03, 2018
BUY
$102.37 - $117.25 $227,773 - $260,881
2,225 New
2,225 $250,000

Others Institutions Holding CRL

# of Institutions
696
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track Richard Pzena's Portfolio

Track Richard Pzena Portfolio

Follow Richard Pzena (Pzena Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email